Cargando…

Guidance for the Harmonisation and Improvement of Economic Evaluations of Personalised Medicine

OBJECTIVE: The objective of this study was to develop guidance contributing to improved consistency and quality in economic evaluations of personalised medicine (PM), given current ambiguity about how to measure the value of PM as well as considerable variation in the methodology and reporting in ec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vellekoop, Heleen, Huygens, Simone, Versteegh, Matthijs, Szilberhorn, László, Zelei, Tamás, Nagy, Balázs, Koleva-Kolarova, Rositsa, Tsiachristas, Apostolos, Wordsworth, Sarah, Rutten-van Mölken, Maureen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8200346/ https://www.ncbi.nlm.nih.gov/pubmed/33860928 http://dx.doi.org/10.1007/s40273-021-01010-z

Ejemplares similares

Financing and Reimbursement Models for Personalised Medicine: A Systematic Review to Identify Current Models and Future Options
por: Koleva-Kolarova, Rositsa, et al.
Publicado: (2022)

Can upfront DPYD extended variant testing reduce toxicity and associated hospital costs of fluoropyrimidine chemotherapy? A propensity score matched analysis of 2022 UK patients
por: Tsiachristas, Apostolos, et al.
Publicado: (2022)

Performing Economic Evaluation of Integrated Care: Highway to Hell or Stairway to Heaven?
por: Tsiachristas, Apostolos, et al.
Publicado: (2016)

Heterogeneity in preferences for outcomes of integrated care for persons with multiple chronic diseases: a latent class analysis of a discrete choice experiment
por: Hoedemakers, Maaike, et al.
Publicado: (2022)

Changes in costs and effects after the implementation of disease management programs in the Netherlands: variability and determinants
por: Tsiachristas, Apostolos, et al.
Publicado: (2014)

Identifying and explaining the variability in development and implementation costs of disease management programs in the Netherlands
por: Tsiachristas, Apostolos, et al.
Publicado: (2014)

The health economic impact of disease management programs for COPD: a systematic literature review and meta-analysis
por: Boland, Melinde RS, et al.
Publicado: (2013)

Are GOLD ABCD groups better associated with health status and costs than GOLD 1234 grades? A cross-sectional study
por: Boland, Melinde RS, et al.
Publicado: (2014)

Value-based person-centred integrated care for frail elderly living at home: a quasi-experimental evaluation using multicriteria decision analysis
por: Hoedemakers, Maaike, et al.
Publicado: (2022)

Exploring the variation in implementation of a COPD disease management programme and its impact on health outcomes: a post hoc analysis of the RECODE cluster randomised trial
por: Boland, Melinde R S, et al.
Publicado: (2015)

Systematic review of model-based economic evaluations of heart valve implantations
por: Huygens, Simone A., et al.
Publicado: (2017)

Update and harmonisation of guidance for the management of diabetic ketoacidosis in children and young people in the UK
por: Rugg-Gunn, Charlotte EM, et al.
Publicado: (2021)

RECODE: Design and baseline results of a cluster randomized trial on cost-effectiveness of integrated COPD management in primary care
por: Kruis, Annemarije L, et al.
Publicado: (2013)

The management of cardiovascular disease in the Netherlands: analysis of different programmes
por: Cramm, Jane M., et al.
Publicado: (2013)

Common challenges faced in EU-funded projects on integrated care for vulnerable persons
por: Rutten-van Mölken, Maureen
Publicado: (2017)

Health-economic benefits of anti-CD20 treatments in relapsing multiple sclerosis estimated using a treatment-sequence model
por: Smets, Ide, et al.
Publicado: (2023)

Genetic-guided pharmacotherapy for venous thromboembolism: a systematic and critical review of economic evaluations
por: Lim, Ka Keat, et al.
Publicado: (2021)

Cost-effectiveness of integrated COPD care: the RECODE cluster randomised trial
por: Boland, Melinde R S, et al.
Publicado: (2015)

Guidance on harmonised methodologies for human health, animal health and ecological risk assessment of combined exposure to multiple chemicals
por: More, Simon John, et al.
Publicado: (2019)

Harmonisation of imaging dosimetry in clinical practice: practical approaches and guidance from the ESR EuroSafe Imaging initiative
por: Vano, Eliseo, et al.
Publicado: (2020)

Harmonisation preserves research resources
por: Vasconcelos, Malte Kohns, et al.
Publicado: (2021)

Congress Theme: Harmonisation and Diversity
por: Neyret, Philippe, et al.
Publicado: (2020)

Methodological Challenges in the Economic Evaluation of a Gene Therapy for RPE65-Mediated Inherited Retinal Disease: The Value of Vision
por: Huygens, Simone A., et al.
Publicado: (2021)

Cost-Utility Analysis of Heberprot-P as an Add-on Therapy to Good Wound Care for Patients in Slovakia with Advanced Diabetic Foot Ulcer
por: Tesar, Tomas, et al.
Publicado: (2017)

How much does a heart valve implantation cost and what are the health care costs afterwards?
por: Huygens, Simone A, et al.
Publicado: (2018)

Effectiveness of integrated disease management for primary care chronic obstructive pulmonary disease patients: results of cluster randomised trial
por: Kruis, Annemarije L, et al.
Publicado: (2014)

Exploring characteristics of COPD patients with clinical improvement after integrated disease management or usual care: post-hoc analysis of the RECODE study
por: Meijer, Eline, et al.
Publicado: (2020)

Development of transferability guidance for integrated care models with special focus on Central and Eastern European countries
por: Kaló, Zoltán, et al.
Publicado: (2020)

Introduction of the harmonised respiratory physiotherapy curriculum
por: Troosters, Thierry, et al.
Publicado: (2019)

Harmonising donor practices for effective aid delivery.
Publicado: (2003)

Towards harmonisation of entomological surveillance in the Mediterranean area
por: Jourdain, Frédéric, et al.
Publicado: (2019)

Harmonisation of biobanking standards in endometrial cancer research
por: Adishesh, M, et al.
Publicado: (2017)

No standarisation or harmonisation in anti-doping testing frequency
por: Cuddihy, Bill
Publicado: (2020)

The perspective on standardisation and harmonisation: the viewpoint of the EASI president
por: Damoiseaux, Jan
Publicado: (2020)

The quest for harmonisation in anti-doping: an Indian perspective
por: Star, Shaun
Publicado: (2022)

Oncologic Thermoradiotherapy: Need for Evidence, Harmonisation, and Innovation
por: Bodis, Stephan, et al.
Publicado: (2022)

Evaluating the harmonisation potential of diverse cohort datasets
por: Bauermeister, Sarah, et al.
Publicado: (2023)

Largely ignored: the impact of the threshold value for a QALY on the importance of a transferability factor
por: Vemer, Pepijn, et al.
Publicado: (2010)

The Potential Impact of Digital Biomarkers in Multiple Sclerosis in The Netherlands: An Early Health Technology Assessment of MS Sherpa
por: Cloosterman, Sonja, et al.
Publicado: (2021)

Contemporary outcomes after surgical aortic valve replacement with bioprostheses and allografts: a systematic review and meta-analysis(†)
por: Huygens, Simone A., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_k7pgijepm200cvi1ktktkhh4o1